CURRICULUM VITAE PERSONAL DETAILS Name:
Bucharest, Colentina Street No 4, Bl 3, St B, App.63
E-mail: catalin.costovici@gmail.com EDUCATION 2006 Postgraduate “ Masterclass in Clinical Oncology “ Malta 2003 Postgraduate ESMO Summer Educational Conference,Edinburgh 2002 Postgraduate Vienna School of Clinical Research-“State of the art in
Postgraduate Second Colorectal Conference ESO (European
2002 Postgraduate Course Of GLEYM (Global Local Young Medical
2001 Postgraduate ESMO Course “ Reading, Writing- Randomized
2001 Postgraduate ESMO Course “Basic Course In Medical Oncology”
2000 Specialty in Medical Oncology and Chemotherapy 1999 Postgraduate “Lymphoma-Leukaemia Course” - Athens, under
the auspice of the European School of Oncology (ESO)
1997 Postgraduate Hemato-Oncology Course - Bucharest, under the
auspice of the University of Leuwen Belgium
1997 Postgraduate Course “Pain Management in advanced cancer” -
1997 Postgraduate ESMO Course “Citostatic Agents-toxicity and
1996-2000 Resident doctor of Medical Oncology at the Institute of Oncology
“Alexandru Trestioreanu”, Bucharest, Department of Medical
1989-1995 The University of Medicine and Pharmacy Craiova, diploma of
1982-1986 The Theoretical High School”Nicolae Balcescu”Pitesti
MEMBER of : - ASCO ( American Society of Clinical Oncology) - ESMO (European Society of Clinical Oncology) (past president of the National Representative of Young Medical Oncologists 1999-2002 - IASLC (International Association for the Study of Lung Cancer) - ESGO(European Society of Gynecologic Oncology) - SROM(Societatea Romana de Oncologie Medicala) WORK HISTORY 1996-97 Stage in Internal Medicine Department “N.Gh.Lupu” Hospital-
1997 Stages in Radiodiagnostics and Cardiology, “N.Gh.Lupu” Hospital-
1998 Stages in Nuclear Medicine and Histo-pathology, Institute of Oncology,
1998-2000 Stage in Medical Oncology, Institute of Oncology, Bucharest 2000 Specialist in Medical Oncology, Institute of Oncology, Bucharest 2001-present Specialist in Medical Oncology at the “ Medical Center for Diagnosis ,
Treatment and Preventive Medicine”, Bucharest
2008-present Specialist in Medical Oncology at the Euroclinic Hospital, Bucharest 2010 Specialist in Medical Oncology at the Anima Medical Center SCIENTIFIC ACTIVITY Articles in specialty publications and books: 1.F.Badulescu,C.Gherasim,E.Gherasim,C.Costovici-Contribution regarding the early detection of mammary gland cancer, 1st European Medical Student Symposium, 1995 - Athens,Greece 2.F. Badulescu,D.Petrisor,V.Roman,L.M.Pop, C.Costovici-The Practical importance of direct standardization into delimitation of territory with maximal incidence of bronchopulmonary cancer in Dolj County, Romania,1992-1996 3.F.Badulescu,C.Costovici,L.Parvulescu,L.M.Pop,A.Dragusin Epidemiologic aspects in colorectal cancer in Dolj County, 1983-1994, Annals of the University of Craiova, Medical Sciences series, 2nd year, 2nd number,1995 4.F.Badulescu,L.Parvulescu,M.Danciulescu,C.Costovici,N.Cherciu- Epidemiological aspects in colorectal cancer in Dolj County, between 1986- 1995, Symposium of Surgery in the Management of malignant tumors - Craiova, Romania 1998 5.I.Mogos,C.Calinescu,C.Costovici-The efficacy of Gemzar@Cisplatin in the management of regionally advanced inoperable cervical cancer, 1999 National Conference of Oncology - Bucharest, Romania 6.Colaboration to the Course of General Oncology for Students-University of Medicine and Pharmacy, Craiova,1997 7.C.Costovici-The Therapy with Gemcitabine in locally advanced and metastatic pancreatic cancer,4th Annual Meeting of Global, Local Young Medical Investigators, 2002, Indianapolis 8.C.Costovici-Case presentation-Temozolomide as adjuvant therapy in the treatment of Glioblastoma after surgery and radiotherapy, Schering-Plough notebook case presentations 9.C.Costovici,F.Badulescu – Superior vena cava syndrome. Handbook of oncologic emergencies(ESMO) 1st edition, 2005 Taylor@Francis 10.C.Costovici-Case presentation- XELOX a safe and efficient treatment im the management of metastatic colon cancer, 6’th Masterclass in Clinical Oncology, 2006 Malta Clinical Trials (First investigator)
1. A phase II open label randomized study of ET-743 given either over 24h
or 3 h infusion in woman with histologically proven, platinum potentially sensitive, recurrent advanced epithelial carcinoma
2. An open safety follow-up study of intranasal fentanyl in the treatment of
breaktrough pain in patients completing either the intranasal pharmacokinetic or the dose schedule finding study and receiving chronic opioid or WHO Cancer Pain Ladder, step 1 analgesics for the background pain
3. A phase III Randomized,Placebo-Controlled, Double-blind study of oral
CCI-779 administred in combination with Letrozole vs Letrozole alone as first line hormonal therapy in postmenopausal women with locally advanced or metastatic breast cancer
4A Multicentre, open-label, extension study to investigate the safety and efficacy of AD 923(Fentanyl sublingual) for the treatment of breakthrough cancer pain in subjects with malignancies
N O N - M E D I C I N A L I N G R E D I E N T SI N T E R A C T I O N S & C O N T R A D I C T I O N SP H A R M A C E U T I C A L C O M M E N T A R Y Vitamin B12 Cyanocobalamin Ingredients (alphabetical) Medicinal: CyanocobalaminNon-medicinal: Cellulose, magnesium stearate vegetable grade (lubricant) Allergens Supplemental vitamin B12 is used primarily to ensure sufficient cyanoco
The Method – New and old Technology Assessment methods Serious game How far would you go to become stronger, fitter or more competitive? Ritalin for your child to improve its educational chances? A robotic arm to boost strength? With the Rathenau Instituut’s new human enhancement app you can put your ethics to the test. spend time in training or use enhancements – mild and rad